Error reporting is mandatory for therapeutic products under an Emergency Use Authorization; errors with COVID-19 vaccines must be sent to VAERS (www.ismp.org/ext/608), while errors with bamlanivimab and casirivimab/imdevimab must be reported to FDA Medwatch (www.ismp.org/ext/609). Please also inform ISMP (www.ismp.org/report-medication-error); your report will help us identify and communicate safety issues!